U.S. market Closed. Opens in 17 hours 6 minutes

DTIL | Precision BioSciences, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for DTIL we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is wealthy, Growth is on medium level and Health is weak.

Valuation (41%)

Company Industry
P/E Ratio (TTM) 3.80 -20.30
PEG Ratio (TTM) -0.06 -5.71
P/S Ratio (TTM) 0.46 50.88
P/B Ratio (TTM) 0.51 29.28
P/FCF Ratio (TTM) -0.71 -8.95
Price to 5YR AVG Earnings Ratio -0.11 -6.52
Price to 5YR AVG FCF Ratio -0.51 -14.78

Profitability (70%)

Company Industry
ROA (TTM) 5.63% -18.85%
ROE (TTM) 17.63% 25.35%
Net Profit Margin (TTM) 11.48% -827.80%
ROIC 5YR AVG 131.46% -26.10%

Growth (55%)

4QTR AVG 3YR AVG 5YR AVG
EPS 19.28% -14.00% -29.11%
Revenue 47.10% 163.09% 101.03%
Net Income 45.57% -13.39% -57.52%
Cash Flow 5.02% 9.08% -75.64%

Health (46%)

Company Industry
Current Ratio (TTM) 9.22 6.09
Quick Ratio (TTM) 9.22 5.87
D/E Ratio (TTM) 0.36 1.00
Interest Coverage (TTM) -8.23 -9.57
Piotroski F-Score 3 4
Altman Z-Score N/A 13.84
LTL to 5YR AVG FCF -0.11 0.07
Shares Outstanding Growth 5YR AVG 20.64% 44.11%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙